Atlas Trials

Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status

Clinical trial NCT03002220 · COMPLETED

Trial details

NCT number
NCT03002220
Sponsor
MedSIR
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-12-21
Primary completion
2020-05-06
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.